Skip to main content
Equibles

FMR LLC

Position in ADCT — ADC Therapeutics SA

CIK 315066 BOSTON, MA
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$142,069
-$505,472 QoQ
Shares Held
132,775
-23.1% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 113 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. ADCT ranks #36 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in ADCT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $142,069 132,775
2026-03-31 $647,541 172,678
2025-12-31 $472,302 133,797
2025-09-30 $533,708 133,427
2025-06-30 $353,398 131,865
2025-03-31 $192,346 136,416
2024-12-31 $252,767 127,019
2024-09-30 $167,081 53,042
2023-12-31 $9 6
2023-09-30 $1,179 1,315
2023-06-30 $2,970 1,382
2023-03-31 $78,865 40,444
2022-12-31 $17,869,257 4,653,453
2022-09-30 $36,984,518 7,673,137
2022-06-30 $61,064,313 7,681,046
2022-03-31 $112,834,564 7,681,046
2021-12-31 $154,987,993 7,672,673
2021-09-30 $208,389,797 7,672,673
2021-06-30 $186,829,586 7,672,673
2021-03-31 $189,460,288 7,761,585
2020-12-31 $248,448,335 7,761,585
2020-09-30 $253,085,588 7,671,585
2020-06-30 $245,482,452 5,244,231